These are the three that were most commonly used by Medicare Part D patients between June 1, 2022, and May 31, according to an Aug. 29 report from CNBC:
Eliquis, a blood thinner made by Bristol-Myers Squibb, was the most commonly used, with 3.7 million Medicare enrollees on the medication.
Jardiance, a low blood sugar medication for Type 2 diabetes made by Boehringer Ingelheim, was used by 1.6 million people.
Xarelto, a blood thinner made by Johnson & Johnson, was used by 1.3 million beneficiaries.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.